Truemors
is reporting from
Member
NP Rank:
NP Rank:
US bans key Indian drug imports
Share: 
by Sanjay Jha | September 17, 2008 at 01:12 am
406 views | 0 Recommendations | 1 comment
Videos
US Department of Justice has alleged Ranbaxy of being involved in systematic fraudulent and submitting false and fabricated information to FDA.
The United States Food and Drug Administration (FDA) says it has banned the import of more than 30 generic drugs made by Indian drug firm Ranbaxy.
The FDA said the decision was made after it found manufacturing quality problems at two of Ranbaxy's factories in India.
The import ban affects some popular generic versions of antibiotics and cholesterol medicines.
Ranbaxy says it is "disappointed" with the decision of US drug authorities.
The FDA said the move would not create any shortages of drugs in the United States, which could be obtained from other sources.
In July, US prosecutors had alleged that Ranbaxy, India's largest pharmaceutical company, deliberately lied about the quality of its low-cost drugs, including those for HIV.
The US Department of Justice wanted the firm to hand over key documents relating to drug testing procedures.
What is NowPublic?
NowPublic lets people work together to cover news events around the world.
Most RecentMost Recommended Comments (1)
at 05:42 on September 18th, 2008
They were banned for contaminating drugs. The US has very strick rules on drugs. The FDA is only being careful due to the contamination of the medications. You can't give bad medicine to people. You can also see this link to read the full story of the banning of drugs.
http://www.nowpublic.com/world/ranbaxy-drops-after-u-s-blocks-import-30-drugs